Everolimus is a Kinase Inhibitor and mTOR Inhibitor Immunosuppressant. The mechanism of action of everolimus is as a Protein Kinase Inhibitor and Cytochrome P450 3A4 Inhibitor and P-Glycoprotein Inhibitor and Cytochrome P450 2D6 Inhibitor and mTOR Inhibitor. The physiologic effect of everolimus is by means of Decreased Immunologic Activity.
CAT No: Z10-101-155
CAS No:159351-69-6
Synonyms/Alias:Afinitor; Certican; Zortress; RAD001; SDZ-RAD
Everolimus is a synthetic derivative of sirolimus (rapamycin) and functions as a highly selective inhibitor of the mammalian target of rapamycin (mTOR), a central regulator of cell growth, proliferation, metabolism, and survival. As a macrolide compound, it is widely recognized in biochemical research for its potent ability to modulate intracellular signaling pathways downstream of mTOR. Its unique mechanism of action, involving the formation of a complex with FKBP12 to inhibit mTOR complex 1 (mTORC1), makes Everolimus a valuable tool for probing cellular processes related to protein synthesis, autophagy, and metabolic regulation. The compound's specificity and well-characterized pharmacology have established it as an essential reagent in molecular and cellular biology studies, particularly those focused on signal transduction and metabolic control.
Signal transduction studies: Researchers frequently employ Everolimus to dissect the intricacies of the mTOR signaling cascade. By selectively inhibiting mTORC1 activity, the compound enables precise investigation of downstream effectors such as S6 kinase and 4E-BP1, which are critical mediators of protein translation and cell cycle progression. Its application facilitates the elucidation of feedback mechanisms and cross-talk between mTOR and other signaling pathways, providing insights into cellular adaptation to nutrient status, growth factors, and stress.
Autophagy modulation: The ability of Everolimus to suppress mTORC1 has made it a preferred agent for inducing autophagy in vitro and in vivo experimental systems. mTORC1 is a key negative regulator of autophagy, and its inhibition by this compound triggers the autophagic process, allowing scientists to study autophagosome formation, lysosomal degradation, and the broader implications of autophagy in cellular homeostasis. Such investigations are pivotal for understanding the role of autophagy in cell survival, differentiation, and response to environmental stimuli.
Cell proliferation and metabolism assays: In cell culture models, Everolimus is routinely used to modulate cell growth and metabolic activity. By attenuating mTORC1-driven anabolic processes, it serves as a valuable tool for assessing the impact of mTOR signaling on cellular proliferation, nutrient uptake, and metabolic reprogramming. This application is particularly relevant in studies examining the interplay between growth factor signaling, energy metabolism, and cell cycle control, as well as in the development of novel strategies for manipulating cell fate in research settings.
Protein synthesis research: The compound's inhibitory action on mTORC1 directly influences cap-dependent translation, making it indispensable for studies aimed at unraveling the regulation of protein synthesis. By blocking phosphorylation of translation initiation factors, Everolimus allows for controlled experiments on translational control mechanisms, ribosome biogenesis, and the selective translation of mRNAs under various physiological and stress conditions. Researchers leverage this property to map translational networks and to understand the molecular basis of growth regulation at the level of protein production.
Drug screening and target validation: Everolimus is also widely utilized in high-throughput screening platforms and target validation studies. Its well-characterized mechanism and consistent biological effects make it an effective positive control or reference compound when evaluating new mTOR pathway modulators or investigating the specificity of candidate molecules. By providing a benchmark for mTORC1 inhibition, it aids in the identification and functional characterization of novel inhibitors, thereby accelerating the discovery of compounds with potential research or industrial applications.
1. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
3. Cationic cell-penetrating peptides are potent furin inhibitors
5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More